Article
The prognostic value of LINC01296 in pan-cancers and the molecular regulatory mechanism in…
OncoTargets and Therapy · 2019 · Liang C, Zhang Y, Zhang Y, Li R, Wang Z, Wei Z, Guo J
Key facts
| Title | The prognostic value of LINC01296 in pan-cancers and the molecular regulatory mechanism in hepatocellular carcinoma: a comprehensive study based on data mining, bioinformatics, and in vitro validation |
|---|---|
| First author | Liang C, Zhang Y, Zhang Y, Li R, Wang Z, Wei Z, Guo J |
| Journal | OncoTargets and Therapy |
| Published | Jul 19, 2019 |
| DOI | 10.2147/OTT.S205853 |
| Devices mentioned | 201807, 205853, BK110039, DEN000008, K022086, K103302, K852441, K854177, K854178, K854179, K854180, K854181 and 7 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 11 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1